Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.66% | 26.74% | 51.69% | 25.65% | 3.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.66% | 26.74% | 51.69% | 25.65% | 3.33% |
| Cost of Revenue | -17.27% | -7.55% | 4.77% | -13.29% | 0.77% |
| Gross Profit | 58.64% | 107.25% | 48.96% | 62.45% | 5.08% |
| SG&A Expenses | 9.01% | 19.84% | 1.98% | 19.85% | 5.15% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | -0.94% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.92% | 13.77% | 0.41% | 14.32% | 0.81% |
| Operating Income | -4.40% | -12.45% | 2.99% | -13.22% | -0.56% |
| Income Before Tax | 35.78% | -163.28% | 48.31% | -40.94% | 15.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.78% | -163.28% | 48.31% | -40.94% | 15.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.78% | -163.28% | 48.31% | -40.94% | 15.96% |
| EBIT | -4.40% | -12.45% | 2.99% | -13.22% | -0.56% |
| EBITDA | -4.44% | -12.68% | 3.05% | -13.57% | -0.52% |
| EPS Basic | 63.58% | -0.88% | 67.77% | 37.38% | 60.87% |
| Normalized Basic EPS | 40.65% | 39.04% | 52.35% | 49.81% | 53.23% |
| EPS Diluted | 63.58% | -0.88% | 67.77% | 37.38% | 60.87% |
| Normalized Diluted EPS | 40.65% | 39.04% | 52.35% | 49.81% | 53.23% |
| Average Basic Shares Outstanding | 76.51% | 84.99% | 103.64% | 125.07% | 114.75% |
| Average Diluted Shares Outstanding | 76.51% | 84.99% | 103.64% | 125.07% | 114.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |